Revolutionizing Medical Diagnostics and Treatment

Tachyon by HQ Technologies is a revolutionary in-vitro point-of-care tool that utilizes advanced long-read sequencing and sophisticated bioinformatics to transform medical diagnostics and treatment. Developed by the British-German MedTech company HQ Science Ltd., and endorsed by global health and defense leaders, Tachyon delivers rapid, precise, and cost-effective genetic analysis directly from clinical samples.
This versatile device excels in various medical applications, from routine clinical care to emergency response. Its capability to quickly and accurately analyze genetic material makes it an invaluable asset in both personalized medicine and public health. By integrating cutting-edge technology with real-time data analysis, Tachyon is set to redefine how personalized diagnostics and treatments are conducted, paving the way for significant advancements in healthcare.

Key Technological Features

Speed and Efficiency:

Tachyon drastically reduces the time needed for gene sequencing and data analysis. It delivers results within hours, enabling healthcare providers to make rapid, informed decisions crucial for effective medical interventions.

Versatility:

This technology is adaptable for numerous medical applications, including oncology, genetics, and personalized medicine. Its universal application makes it invaluable in healthcare, research, and biotechnology sectors.

Artificial Intelligence:

Tachyon uses advanced AI algorithms for fast and precise data analysis. This enhances the efficiency of diagnostics, providing detailed insights that inform personalized treatment plans tailored to individual patients.

High Sample Throughput:

Designed to process multiple samples simultaneously, Tachyon increases the capacity for high-throughput sequencing. This significantly cuts down overall processing time, making it ideal for settings requiring rapid turnaround.

Cost-Efficiency:

By streamlining sequencing processes and cutting analysis times, Tachyon lowers the costs associated with genetic diagnostics, making advanced medical technology more accessible and affordable.

Use Cases

Radiation Preparedness - Radiological Emergency Response:

Tachyon Guardian, a specialized version of the device, is pivotal in radiological emergency preparedness. In collaboration with the UK Health Security Agency (UKHSA), Tachyon is going to integrated into the UK's emergency protocols. It can rapidly assess radiation exposure in blood samples, reducing response times from days to hours. This capability greatly enhances the efficiency of emergency triage and national response strategies.

Oncoradio DX - Personalized Radiation Oncology:

In radiation oncology, Tachyon provides highly personalized diagnostics by tailoring radiation therapy to each patient’s genetic profile. It optimizes dosing to maximize treatment efficacy and minimize side effects. Tachyon’s rapid, real-time analysis of molecular data allows for immediate adjustments to treatment plans, significantly improving clinical outcomes and ensuring precise, effective radiation therapy.

Antimicrobial Resistance (AMR) - Combatting AMR:

Tachyon is adept at addressing antimicrobial resistance (AMR) by rapidly sequencing pathogen genomes and detecting resistance genes and mutations. This detailed genetic mapping offers critical insights into the pathogen’s capabilities, guiding immediate clinical responses. Tachyon’s comprehensive analysis extends to plasmids and genetic elements that spread resistance, enabling personalized antimicrobial therapy and supporting efforts to monitor and control resistant pathogens.

Pathogen Detection - Advanced Pathogen Identification:

Tachyon revolutionizes pathogen detection by decoding entire genomes of bacteria, viruses, or fungi directly from clinical samples. This allows for the swift and accurate identification of pathogens, including closely related strains. The device provides detailed genetic insights into pathogen behavior, such as virulence factors and resistance genes, which are crucial for developing targeted and effective treatment strategies.

Sepsis Management - Transformative Sepsis Care:

In managing sepsis, a critical condition caused by the body’s response to infection, Tachyon's rapid sequencing capabilities are vital. It quickly identifies a wide range of pathogens from a patient’s blood, facilitating the timely initiation of appropriate treatment and improving survival rates. Beyond pathogen identification, Tachyon provides insights into resistance genes, allowing for precise tailoring of antimicrobial therapy. Its real-time data processing produces actionable reports, enabling quick and informed clinical decisions that enhance sepsis management and reduce the risk of complications and mortality.

UNLOCK END-TO-END MOLECULAR DIAGNOSTICS AT THE POINT-OF-CARE

Tachyon is a cutting-edge point-of-care molecular diagnostics device that integrates nanopore sequencing with real-time gene expression analysis.

15x faster, 2x cheaper. By delivering real-time results directly at the point of care and eliminating the need for off-site processing or specialised bioinformatics expertise, Tachyon reduces diagnostic turnaround times from weeks to under 24 hours. This innovation positions us at the forefront of precision medicine, offering significant value through enhanced efficiency, cost-effectiveness, and advancement in patient-centric care.

Advantages of the Tachyon Platform

Decentralisation:

Tachyon operates at the point of care, eliminating the need for shipping samples or investing in dedicated laboratories and bioinformatics personnel. This decentralised approach streamlines diagnostics and enhances accessibility within clinical settings.

Speed-to-Result:

Adaptable Delivering results within minutes to hours, depending on diagnostic depth and requirements, Tachyon significantly reduces turnaround times compared to traditional methods.

2 to 4 times cheaper:

Tachyon reduces overall diagnostic costs, making advanced molecular diagnostics more affordable and cost-efficient.

High Throughput:

The platform supports the simultaneous analysis of multiple samples, enhancing efficiency and productivity in both clinical and research environments.

Adaptability and Flexibility: